Baxter bounces back in Q3
This article was originally published in Scrip
Executive Summary
Baxter has raised the lower-end of its full-year guidance after its third-quarter net income rose by 12% to $595 million, recovering from a disappointing second quarter (scripintelligence.com, 23 July 2010).